The efficacy of tetracyclines in peripheral and intracerebral prion infection

Ada De Luigi, Laura Colombo, Luisa Diomede, Raffaella Capobianco, Michela Mangieri, Claudia Miccolo, Lucia Limido, Gianluigi Forloni, Fabrizio Tagliavini, Mario Salmona

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

We have previously shown that tetracyclines interact with and reverse the protease resistance of pathological prion protein extracted from scrapie-infected animals and patients with all forms of Creutzfeldt-Jakob disease, lowering the prion titre and prolonging survival of cerebrally infected animals. To investigate the effectiveness of these drugs as anti-prion agent Syrian hamsters were inoculated intramuscularly or subcutaneously with 263K scraple strain at a 10-4 dilution. Tetracyclines were injected intramuscularly or intraperitoneally at the doseo f 10 mg/kg. A single intramuscular dose of doxycycline one hour after infection in same site of inoculation prolonged median survival by 64%. Intraperitoneal doses of tetracyclines every two days for 40 or 44 days increased survival time by 25% (doxycycline), 32% (tetracycline); and 81% (minocycline) after intramuscular infection, and 35% (doxycycline) after subcutaneous infection. To extend the therapeutic potential of tetracyclines, we investigated the efficacy of direct infusion of tetracyclines in advanced infection. Since intracerebroventricular infusion of tetracycline solutions can cause overt acute toxicity in animals, we entrapped the drugs in liposomes. Animals were inoculated intracerebrally with a 10-4 dilution of the 263K scrapie strain. A single intracerebroventricular infusion of 25μg/ 20 μl of doxycycline or minocycline entrapped in liposomes was administered 60 days after inoculation, when 50% of animals showed initial symptoms of the disease. Median survival increased of 8.1% with doxycycline and 10% with minocycline. These data suggest that tetracyclines might have therapeutic potential for humans.

Original languageEnglish
Article numbere1888
JournalPLoS One
Volume3
Issue number3
DOIs
Publication statusPublished - Mar 26 2008

Fingerprint

Tetracyclines
tetracyclines
Prions
prions
doxycycline
Doxycycline
minocycline
Animals
Minocycline
Infection
infection
Intraventricular Infusions
Scrapie
Survival
scrapie
animals
Tetracycline
tetracycline
Liposomes
Dilution

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

The efficacy of tetracyclines in peripheral and intracerebral prion infection. / De Luigi, Ada; Colombo, Laura; Diomede, Luisa; Capobianco, Raffaella; Mangieri, Michela; Miccolo, Claudia; Limido, Lucia; Forloni, Gianluigi; Tagliavini, Fabrizio; Salmona, Mario.

In: PLoS One, Vol. 3, No. 3, e1888, 26.03.2008.

Research output: Contribution to journalArticle

De Luigi, Ada ; Colombo, Laura ; Diomede, Luisa ; Capobianco, Raffaella ; Mangieri, Michela ; Miccolo, Claudia ; Limido, Lucia ; Forloni, Gianluigi ; Tagliavini, Fabrizio ; Salmona, Mario. / The efficacy of tetracyclines in peripheral and intracerebral prion infection. In: PLoS One. 2008 ; Vol. 3, No. 3.
@article{750919f446554ec9bc3c0ebe34bcb764,
title = "The efficacy of tetracyclines in peripheral and intracerebral prion infection",
abstract = "We have previously shown that tetracyclines interact with and reverse the protease resistance of pathological prion protein extracted from scrapie-infected animals and patients with all forms of Creutzfeldt-Jakob disease, lowering the prion titre and prolonging survival of cerebrally infected animals. To investigate the effectiveness of these drugs as anti-prion agent Syrian hamsters were inoculated intramuscularly or subcutaneously with 263K scraple strain at a 10-4 dilution. Tetracyclines were injected intramuscularly or intraperitoneally at the doseo f 10 mg/kg. A single intramuscular dose of doxycycline one hour after infection in same site of inoculation prolonged median survival by 64{\%}. Intraperitoneal doses of tetracyclines every two days for 40 or 44 days increased survival time by 25{\%} (doxycycline), 32{\%} (tetracycline); and 81{\%} (minocycline) after intramuscular infection, and 35{\%} (doxycycline) after subcutaneous infection. To extend the therapeutic potential of tetracyclines, we investigated the efficacy of direct infusion of tetracyclines in advanced infection. Since intracerebroventricular infusion of tetracycline solutions can cause overt acute toxicity in animals, we entrapped the drugs in liposomes. Animals were inoculated intracerebrally with a 10-4 dilution of the 263K scrapie strain. A single intracerebroventricular infusion of 25μg/ 20 μl of doxycycline or minocycline entrapped in liposomes was administered 60 days after inoculation, when 50{\%} of animals showed initial symptoms of the disease. Median survival increased of 8.1{\%} with doxycycline and 10{\%} with minocycline. These data suggest that tetracyclines might have therapeutic potential for humans.",
author = "{De Luigi}, Ada and Laura Colombo and Luisa Diomede and Raffaella Capobianco and Michela Mangieri and Claudia Miccolo and Lucia Limido and Gianluigi Forloni and Fabrizio Tagliavini and Mario Salmona",
year = "2008",
month = "3",
day = "26",
doi = "10.1371/journal.pone.0001888",
language = "English",
volume = "3",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - The efficacy of tetracyclines in peripheral and intracerebral prion infection

AU - De Luigi, Ada

AU - Colombo, Laura

AU - Diomede, Luisa

AU - Capobianco, Raffaella

AU - Mangieri, Michela

AU - Miccolo, Claudia

AU - Limido, Lucia

AU - Forloni, Gianluigi

AU - Tagliavini, Fabrizio

AU - Salmona, Mario

PY - 2008/3/26

Y1 - 2008/3/26

N2 - We have previously shown that tetracyclines interact with and reverse the protease resistance of pathological prion protein extracted from scrapie-infected animals and patients with all forms of Creutzfeldt-Jakob disease, lowering the prion titre and prolonging survival of cerebrally infected animals. To investigate the effectiveness of these drugs as anti-prion agent Syrian hamsters were inoculated intramuscularly or subcutaneously with 263K scraple strain at a 10-4 dilution. Tetracyclines were injected intramuscularly or intraperitoneally at the doseo f 10 mg/kg. A single intramuscular dose of doxycycline one hour after infection in same site of inoculation prolonged median survival by 64%. Intraperitoneal doses of tetracyclines every two days for 40 or 44 days increased survival time by 25% (doxycycline), 32% (tetracycline); and 81% (minocycline) after intramuscular infection, and 35% (doxycycline) after subcutaneous infection. To extend the therapeutic potential of tetracyclines, we investigated the efficacy of direct infusion of tetracyclines in advanced infection. Since intracerebroventricular infusion of tetracycline solutions can cause overt acute toxicity in animals, we entrapped the drugs in liposomes. Animals were inoculated intracerebrally with a 10-4 dilution of the 263K scrapie strain. A single intracerebroventricular infusion of 25μg/ 20 μl of doxycycline or minocycline entrapped in liposomes was administered 60 days after inoculation, when 50% of animals showed initial symptoms of the disease. Median survival increased of 8.1% with doxycycline and 10% with minocycline. These data suggest that tetracyclines might have therapeutic potential for humans.

AB - We have previously shown that tetracyclines interact with and reverse the protease resistance of pathological prion protein extracted from scrapie-infected animals and patients with all forms of Creutzfeldt-Jakob disease, lowering the prion titre and prolonging survival of cerebrally infected animals. To investigate the effectiveness of these drugs as anti-prion agent Syrian hamsters were inoculated intramuscularly or subcutaneously with 263K scraple strain at a 10-4 dilution. Tetracyclines were injected intramuscularly or intraperitoneally at the doseo f 10 mg/kg. A single intramuscular dose of doxycycline one hour after infection in same site of inoculation prolonged median survival by 64%. Intraperitoneal doses of tetracyclines every two days for 40 or 44 days increased survival time by 25% (doxycycline), 32% (tetracycline); and 81% (minocycline) after intramuscular infection, and 35% (doxycycline) after subcutaneous infection. To extend the therapeutic potential of tetracyclines, we investigated the efficacy of direct infusion of tetracyclines in advanced infection. Since intracerebroventricular infusion of tetracycline solutions can cause overt acute toxicity in animals, we entrapped the drugs in liposomes. Animals were inoculated intracerebrally with a 10-4 dilution of the 263K scrapie strain. A single intracerebroventricular infusion of 25μg/ 20 μl of doxycycline or minocycline entrapped in liposomes was administered 60 days after inoculation, when 50% of animals showed initial symptoms of the disease. Median survival increased of 8.1% with doxycycline and 10% with minocycline. These data suggest that tetracyclines might have therapeutic potential for humans.

UR - http://www.scopus.com/inward/record.url?scp=46749109619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749109619&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0001888

DO - 10.1371/journal.pone.0001888

M3 - Article

C2 - 18365024

AN - SCOPUS:46749109619

VL - 3

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e1888

ER -